000 01330 a2200385 4500
005 20250513081924.0
264 0 _c19930607
008 199306s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(05)80444-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuijgens, P C
245 0 0 _aThe prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_c1993
300 _a926-7 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCandidiasis, Oral
_xprevention & control
650 0 4 _aFemale
650 0 4 _aFluconazole
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid
_xcomplications
650 0 4 _aLymphoma
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xcomplications
700 1 _avan Loenen, A C
700 1 _aSimoons-Smit, A M
700 1 _aProoy, E
700 1 _aOssenkoppele, G J
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 29A
_gno. 6
_gp. 926-7
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(05)80444-7
_zAvailable from publisher's website
999 _c8484258
_d8484258